ArticleJournal of assisted reproduction and genetics2026
Improving women's healthcare providers' knowledge about fragile X-associated primary ovarian insufficiency through a novel educational tool.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeGaps in knowledge among women's healthcare providers have contributed to diagnostic delays and delayed care for women with fragile X-associated primary ovarian insufficiency (FXPOI). The objective of this study was to assess if an educational tool could improve women's healthcare providers' knowledge of FXPOI.
methodsA one-page educational tool about the premutation and FXPOI was developed. To assess the impact, a pre- and post-intervention survey was given to 95 providers. The post-intervention survey was emailed approximately 1 month after the pre-intervention survey. Surveys consisted of 12 knowledge-based questions (12 points total). Additional information collected included demographics, routine POI workup, comfort level explaining carrier screening results, and feedback on the tool.
resultsProvider knowledge significantly improved from 7.34/12 (± 1.75) to 8.66/12 (± 2.30) (p < 0.0001). Significant predictors of pre-intervention knowledge included provider type, specialty, presence of a genetic counselor (GC) in clinic, and graduation year. Physicians outperformed nurse practitioners and nurse midwives (p < 0.0128). Reproductive endocrinologists and maternal-fetal medicine providers outperformed other specialties (p < 0.0001). Providers with a GC in the clinic performed better than those without (p = 0.0128). Providers who graduated between 2010 and 2019 outperformed more recent graduates (p = 0.0348). No significant predictors were identified for post-intervention scores.
conclusionsThe implementation of our novel educational tool led to measurable improvement in provider knowledge regarding FXPOI and the fragile X premutation. The absence of significant demographic predictor variables on the post-intervention survey suggests that the educational tool may help reduce provider gaps in knowledge and ultimately reduce time to diagnosis and improve reproductive care for women with FXPOI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.